Nitto Avecia
Sarah Lewis currently serves as a Project Manager at Nitto Denko Avecia Inc. since November 2019, following a role as a Technical Field Representative at CEM Corporation from October 2018 to October 2019. Prior to these positions, Sarah was a Postdoctoral Research Fellow at the Massachusetts Institute of Technology from September 2015 to October 2018, and a Graduate Student and Teaching Assistant at the University of Missouri from August 2008 to May 2015, where Sarah instructed laboratory experiments in chemistry and achieved an average teaching evaluation score of 3. Sarah holds a Post Doctoral Fellowship in Biological Engineering from the Massachusetts Institute of Technology and a PhD in Chemistry, as well as an MS in Chemistry, both from the University of Missouri-Columbia, alongside a BS in Biochemistry from Texas Tech University.
Nitto Avecia
1 followers
Oligonucleotides are giving rise to a new generation of therapeutics—and Nitto Avecia is helping lead the way. With more than 25 years’ experience in oligonucleotide development and production, we are the partner of choice for pharmaceutical innovators creating new drugs with the power to transform treatment for a wide range of diseases. In partnership with Nitto Avecia Pharma Services, Nitto Avecia is the first CMO that offers a comprehensive, end-to-end oligonucleotide solution. This offers the advantage of a single, expert partner handling the entire process—from drug substance through drug product manufacturing—with flexible solutions and consistent reliability and quality.